| |
NEWS RELEASES
Construction starts on children’s AIDS center in
Mwanza, Tanzania
HOUSTON – (April 24, 2009) –
Construction of a new center of excellence to provide comprehensive
pediatric HIV/AIDS care to children and their families officially
began today in Mwanza, Tanzania. The center is part of a network
directed by the
Baylor
International Pediatric AIDS Initiative and Texas Children's
Hospital.
This is the second groundbreaking for a BIPAI clinic this month in
Tanzania. The scaled up effort to provide care in the large country
in East Africa is the result of a public-private partnership that
includes the Tanzanian government, the U.S. President’s Emergency
Plan for AIDS Relief (PEPFAR) through USAID, BIPAI’s sponsoring
institutions (Baylor College of Medicine and Texas Children’s
Hospital), the Bristol-Myers Squibb Foundation and Jan and Dan
Duncan.
| |
 |
| |
Participating in the
groundbreaking are, from left, the Rt. Rev. Bishop
Balina, Chairman of the Board of Governors of Bugando
Medical Centre; Dr. Charles Majinge, director general of
Bugando Medical Centre; Honorable Elinasi Palangyo, the
guest of honor and District Commissioner of Sengerema;
Phangisile Mtshali, Director of Bristol-Myers Squibb
Foundation; Dr. Patrick Swai, senior project adviser,
U.S. Agency for International Development and Michael
Mizwa, BIPAI Vice President- International Affairs.
|
“The new BIPAI program in Tanzania is
the result of a true public-private partnership that will benefit
thousands of Tanzanian children and families,” said
Dr. Mark Kline, president of BIPAI, professor of pediatrics at
BCM and chief of
retrovirology at Texas Children’s.
On hand for the groundbreaking ceremony were the Honorable Elinasi
Palangyo, the guest of honor and District Commissioner of Sengerema;
the Rt. Rev. Bishop Balina, Chairman of the Board of Governors of
Bugando Medical Centre; the Honorable Leonard Bihonde, Mayor of
Mwanza City; Dr. Meshale Mmasi, Regional Medical Officer; Dr.
Patrick Swai, representing the U.S. Government; Gene Peuse,
representing the U.S. Agency for International Development; Dr.
Charles Majinge, director general of Bugando Medical Centre;
Phangisile Mtshali, Director of Bristol-Myers Squibb Foundation;
Michael Mizwa, BIPAI Vice President of International Affairs; and
Dr. Susan Gillespie and Susan Kelly, BIPAI-Tanzania medical and
program directors. Construction of the center is expected to be
completed by May 2010.
“Last year, over 1,400 infants aged between one to 18 months were
tested at BMC and 18 percent of these infants were detected
HIV-positive. Indeed it is estimated that up to 50 percent of
HIV/AIDS infected babies in Tanzania are likely to die before the
age of 24 months, if no intervention measures are taken to put
things on the right course. We do hope that the BIPAI Initiative and
the Children’s Clinical Centre of Excellence will transform the
child well-being in the Lake Zone and Tanzania in general,” said
Majinge, director general of the Bugando Medical Centre.
In his speech delivered by the District Commissioner, Prof. David H.
Mwakyusa, the Minister of Health and Social Welfare, said, “The
Centre of Excellence for pediatric care, the building and program of
which we are marking its beginning today, will one way or another
address these challenges. It is for this reason that the Ministry of
Health and Social Welfare and the Government of the United Republic
of Tanzania highly appreciate this project that has come timely and
in the area where the demand is high”
The Mwanza region has a population of nearly 3 million and a 7.2
percent HIV prevalence rate. Earlier this month, a groundbreaking
ceremony was held for a new center in Mbeya, Tanzania. Few resources
have been available in Tanzania for the care and treatment of
HIV-infected children.
“This public-private partnership exemplifies the good work being
carried out by the American people toward strengthening the health
of all Tanzanians. We look forward to continuing working together in
partnership to ensure this country's children have healthier lives
and a more prosperous future,” said Larry André, acting U.S.
ambassador to Tanzania.
The new center in Mwanza will be affiliated with and located on the
campus of the Bugando Medical Centre.
The Bristol-Myers Squibb Foundation is supporting the center’s
construction. The company also partners with BCM in sponsoring the
Pediatric AIDS Corps, a program that supplements health care workers
in Africa with American physicians. The Mwanza center will be
staffed primarily by local health care workers, who will be assisted
by PAC doctors.
“Bristol-Myers Squibb Foundation is proud to support the development
of this Center of Excellence and help enhance the lives of children
in the Mwanza region. These children deserve the very best medical
care available but have had limited access in the past," said John
Damonti, president of the Bristol-Myers Squibb Foundation. "We have
already begun to help provide children in this community with
quality care through the transitional facility, and this
groundbreaking is an important step forward in improving health
outcomes over the long term."
Last August, PEPFAR announced a grant award of $22.5 million over
five years to support the operations of the two centers of
excellence in Tanzania, along with the satellite facilities that
will develop from the centers.
Through the two centers and the satellite clinics, 20,000 children
will receive care.
The two centers in Tanzania are the eighth and ninth established by
BIPAI. The first center of excellence opened in Romania in 2001. The
Houston-based group has centers of excellence throughout Africa, but
this is the first time two centers have been located in one country.
Other centers of excellence are located in Botswana, Malawi, Uganda,
Lesotho, Burkina Faso and Swaziland. |
|